Neuphoria Therapeutics Inc Cash Flow Reinvestment Rate
Neuphoria Therapeutics Inc cash flow reinvestment rate. Neuphoria Therapeutics Inc (NEUP) has a Cash Flow Reinvestment Rate of 0.00x as of June 2026, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.19 Million. Explore cash flow to debt ratio of Neuphoria Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Neuphoria Therapeutics Inc (2015–2025)
Cash flow reinvestment rate of Neuphoria Therapeutics Inc from 2015 to 2025. Historical reinvestment intensity for Neuphoria Therapeutics Inc across 2 annual periods. Explore Neuphoria Therapeutics Inc (NEUP) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Neuphoria Therapeutics Inc Cash Flow Reinvestment Rate by Year (2015–2025)
Neuphoria Therapeutics Inc cash flow reinvestment rate by year from 2015 to 2025. Year-by-year capital reinvestment analysis for Neuphoria Therapeutics Inc. For the full cash flow conversion analysis, see Neuphoria Therapeutics Inc cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $0.00 | $77.23 Million | $0.00 | ▼ -100.0% |
| 2015 | 0.17x | $846.26K | $4.94 Million | $846.26K | — |